HSV-2 prophylactic vaccine (Genocea Biosciences)

N/A

Report date: 2025/06/11 10:41:10

Base Information

Drug NameHSV-2 prophylactic vaccine (Genocea Biosciences)

Drug Alias Nameprophylactic protein subunit vaccine (Genocea Biosciences)GENO-2HSV-PX

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionCluster of differentiation 8 stimulantsT-cell surface antigen CD4 agonists

TargetsT-cell surface antigen CD4Cluster of differentiation 8

Therapy Area/IndicationsHerpes Simplex Virus Type 2 Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGenocea Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesGenocea Biosciences Inc

Inactive CompaniesN/A

Active IndicationsHerpes Simplex Virus Type 2 Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A